How is Floating-Harbor syndrome diagnosed?

Floating-Harbor syndrome is primarily diagnosed through clinical evaluation of characteristic physical features and developmental delays, followed by molecular genetic testing to identify a pathogenic variant in the SRCAP gene. Because this is a rare condition, the diagnostic process often involves a multidisciplinary team, including clinical geneticists, who confirm the diagnosis by matching a patient’s unique profile against established clinical criteria and genetic data.

How is Floating-Harbor syndrome diagnosed?

The diagnosis of Floating-Harbor syndrome is a multi-stage journey that begins with a suspicion based on clinical presentation. Physicians look for a constellation of features, including short stature (often starting in early childhood), delayed bone age, and specific craniofacial characteristics such as a triangular face, deep-set eyes, and a prominent nose. Because Floating-Harbor syndrome is rare, there is no single "blood test" that detects it; instead, diagnosis relies on clinical observation followed by confirmatory genomic analysis.

What is the role of genetic testing in Floating-Harbor syndrome?

The definitive diagnosis of Floating-Harbor syndrome is confirmed via molecular genetic testing. Scientists have identified that the condition is caused by heterozygous mutations in the SRCAP (Snf2-related CBP activator protein) gene. Clinical geneticists typically use one of the following methods to identify these mutations:

• Targeted Gene Sequencing: Analyzing the SRCAP gene specifically if the clinical suspicion is high.


• Whole Exome Sequencing (WES): Often used when a patient presents with non-specific developmental delays, allowing clinicians to screen all protein-coding genes to uncover the SRCAP mutation.


• Chromosomal Microarray: While this may not detect the point mutations associated with Floating-Harbor syndrome, it is often performed early in the diagnostic odyssey to rule out other chromosomal abnormalities.

Why is the diagnostic journey so long for patients?

Many individuals within the DiseaseMaps community have experienced a "diagnostic odyssey," where it takes years to receive an accurate label for their symptoms. Because Floating-Harbor syndrome is rare, many pediatricians and general practitioners may never encounter a case in their entire career. This often leads to fragmented care, where symptoms like speech delays or growth issues are treated in isolation rather than being recognized as part of a single genetic syndrome. It is entirely valid to feel frustrated by this process; the lack of awareness in the general medical community often places the burden of advocacy on the patient and their family.

What conditions are in the differential diagnosis?

Because Floating-Harbor syndrome presents with growth retardation and developmental delays, it is frequently confused with other conditions. Clinicians must perform a differential diagnosis to distinguish it from:

• Rubinstein-Taybi syndrome: Shares some facial features and developmental patterns.


• Silver-Russell syndrome: Also associated with significant growth restriction.


• 3M syndrome: Characterized by short stature and specific facial features.


• Other microdeletion syndromes: Various genetic conditions can mimic the developmental profile of Floating-Harbor syndrome, making expert genetic consultation essential.

Next steps

• Consult a Clinical Geneticist: If you suspect Floating-Harbor syndrome, ask your primary care physician for a referral to a geneticist who specializes in pediatric developmental disorders.


• Connect with the Community: Join the 11 members already on DiseaseMaps.org who are living with this condition to share insights and diagnostic tips.


• Gather Records: Compile growth charts, speech therapy evaluations, and any previous genetic reports to provide your specialist with a comprehensive history.


• Seek Centers of Excellence: Look for university-affiliated rare disease centers, as they are more likely to have access to the latest genomic diagnostic tools.

Medical disclaimer: This content is for educational purposes only and does not constitute medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Floating-Harbor syndrome resources.


• OMIM (Online Mendelian Inheritance in Man): Entry #136140 for SRCAP-related disorders.


• Orphanet: Database for rare diseases and orphan drugs.


• PubMed: Peer-reviewed clinical literature on the phenotypic spectrum of SRCAP mutations.